Combating Counterfeit Pharmaceuticals Act of 2025

[AI summary unavailable — showing source text] [Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 3134 Introduced in Senate (IS)] <DOC> 119th CONGRESS 1st Session S. 3134 To amend the Fentanyl Sanctions Act to address trafficking of copy-cat and counterfeit drugs and active pharmaceutical ingredients, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES November 6, 2025 Mr. Cotton (for himself and Mr. Ricketts) introduced the following bill; which was read twice and referred to the Committee on Banking, Housing, and Urban Affairs _______________________________________________________________________ A BILL To amend the Fentanyl Sanctions Act to address trafficking of copy-cat and counterfeit drugs and active pharmaceutical ingredients, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Combating Counterfeit Pharmaceuticals Act of 2025''. SEC. 2. DEFINITIONS. Section 7203 of the Fentanyl Sanctions Act (21 U.S.C. 2302) is amended-- (1) by redesignating paragraphs (4) through…